Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹17Cr
Rev Gr TTM
Revenue Growth TTM
25.99%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

PARMCOS-B
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 28.8 | -10.9 | -6.6 | -20.2 | -31.4 | -21.4 | -10.0 | -11.5 | 17.3 | 25.8 | 69.4 | -5.9 |
| 7 | 4 | 6 | 6 | 5 | 3 | 5 | 5 | 6 | 4 | 8 | 5 |
Operating Profit Operating ProfitCr |
| 8.9 | 10.6 | -6.5 | 5.3 | -0.2 | 8.1 | 6.0 | 6.1 | 0.7 | 9.4 | 4.7 | 4.0 |
Other Income Other IncomeCr | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 102.6 | -20.0 | 60.0 | 50.0 | -520.0 | -75.0 | -93.8 | -33.3 | 90.5 | -700.0 | 1,200.0 | 50.0 |
| 0.7 | 0.8 | 2.8 | 0.5 | -4.1 | 0.3 | 0.2 | 0.4 | -0.3 | -1.3 | 1.5 | 0.6 |
| 0.1 | 0.1 | 0.3 | 0.3 | -1.7 | 0.1 | 0.1 | 0.2 | -0.1 | -0.5 | 0.9 | 0.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 2.1 | 1.5 | -29.0 | -39.8 | 4.2 | 10.6 | -27.6 | 15.3 | 32.4 | -18.4 | -6.5 | 20.6 |
| 43 | 42 | 30 | 16 | 17 | 20 | 15 | 21 | 24 | 21 | 19 | 23 |
Operating Profit Operating ProfitCr |
| 10.2 | 13.7 | 15.3 | 21.4 | 20.1 | 16.2 | 14.8 | -4.6 | 9.9 | 1.9 | 4.8 | 4.5 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 0 | 2 | 1 | 1 |
Interest Expense Interest ExpenseCr | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Depreciation DepreciationCr | 1 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 2 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 15.6 | -54.0 | -111.7 | 139.2 | -448.0 | 7.8 | 391.1 | -42.9 | 8.2 | -89.9 | 40.2 | 166.7 |
| 3.6 | 1.6 | -0.3 | 0.2 | -0.6 | -0.5 | 2.0 | 1.0 | 0.8 | 0.1 | 0.1 | 0.3 |
| 3.6 | 1.6 | -0.2 | 0.1 | -0.3 | -0.2 | 0.7 | 0.4 | 0.4 | 0.0 | 0.1 | 0.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| 19 | 19 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 16 | 16 |
Current Liabilities Current LiabilitiesCr | 27 | 28 | 21 | 19 | 21 | 23 | 22 | 19 | 15 | 15 | 16 | 16 |
Non Current Liabilities Non Current LiabilitiesCr | 14 | 13 | 9 | 7 | 8 | 7 | 7 | 9 | 8 | 5 | 4 | 3 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 38 | 39 | 27 | 25 | 22 | 25 | 25 | 25 | 21 | 25 | 26 | 25 |
Non Current Assets Non Current AssetsCr | 27 | 26 | 24 | 22 | 26 | 25 | 24 | 23 | 22 | 15 | 15 | 14 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 7 | 0 | 6 | 4 | 4 | 4 | 2 | 1 | 4 | 0 | 1 |
Investing Cash Flow Investing Cash FlowCr | -8 | 2 | -1 | 0 | 0 | 0 | 0 | 4 | 0 | 2 | 1 |
Financing Cash Flow Financing Cash FlowCr | 1 | -4 | -6 | -4 | -4 | -4 | -2 | -5 | -4 | -2 | -2 |
|
Free Cash Flow Free Cash FlowCr | -1 | 2 | 6 | 4 | 4 | 4 | 2 | 5 | 4 | 1 | 1 |
| 413.4 | 48.9 | -6,878.6 | 10,334.6 | -3,455.6 | -3,605.7 | 660.9 | 417.3 | 1,725.0 | -1,100.0 | 4,681.3 |
CFO To EBITDA CFO To EBITDA% | 145.7 | 5.8 | 120.8 | 84.4 | 100.4 | 108.5 | 87.5 | -88.8 | 137.8 | -55.8 | 142.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 16 | 17 | 16 | 14 | 9 | 6 | 8 | 23 | 17 | 18 | 19 |
Price To Earnings Price To Earnings | 9.8 | 22.2 | 0.0 | 355.6 | 0.0 | 0.0 | 22.6 | 116.0 | 78.2 | 944.8 | 666.7 |
Price To Sales Price To Sales | 0.3 | 0.3 | 0.5 | 0.7 | 0.4 | 0.2 | 0.5 | 1.1 | 0.6 | 0.8 | 0.9 |
Price To Book Price To Book | 0.7 | 0.7 | 0.8 | 0.7 | 0.5 | 0.3 | 0.4 | 1.1 | 0.8 | 0.9 | 0.9 |
| 7.5 | 5.6 | 6.3 | 6.9 | 6.1 | 5.5 | 8.8 | -37.7 | 10.8 | 68.9 | 29.8 |
Profitability Ratios Profitability Ratios |
| 35.0 | 39.4 | 52.7 | 79.7 | 78.3 | 77.0 | 82.6 | 69.3 | 54.5 | 28.9 | 35.9 |
| 10.2 | 13.7 | 15.3 | 21.4 | 20.1 | 16.2 | 14.8 | -4.6 | 9.9 | 1.9 | 4.8 |
| 3.6 | 1.6 | -0.3 | 0.2 | -0.6 | -0.5 | 2.0 | 1.0 | 0.8 | 0.1 | 0.1 |
| 9.2 | 9.7 | 8.4 | 8.2 | 7.9 | 7.5 | 7.7 | 8.2 | 6.2 | 5.6 | 5.2 |
| 7.4 | 3.3 | -0.5 | 0.2 | -0.7 | -0.6 | 1.8 | 1.0 | 1.1 | 0.1 | 0.1 |
| 2.7 | 1.2 | -0.2 | 0.1 | -0.3 | -0.2 | 0.7 | 0.4 | 0.5 | 0.1 | 0.1 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Paramount Cosmetics (India) Limited (PCIL) is a specialized player in the Indian traditional color cosmetics segment, primarily operating under the well-established brand name **'SHILPA'**. Since **1985**, the company has focused on a single business segment involving products such as **Sticker Bindis, Kumkum, Sindoor, and Kajal**. PCIL is currently undergoing a fundamental strategic transformation, pivoting from a manufacturing-heavy model to a lean, **selling and distribution-focused entity** designed to capture the evolving "Indie Beauty" market.
---
### **Strategic Pivot: Transition to a Distribution-Led Model**
Effective **December 1, 2022**, PCIL underwent a significant structural shift. The rights to manufacture and market 'Shilpa' products were withdrawn by the brand owner, **Paramount Kum Kum Private Limited (PKPL)**, a related party.
* **Current Operational Role:** PCIL now serves as the primary **selling and distribution partner** for 'Shilpa' products manufactured by PKPL. This arrangement allows PCIL to onboard other third-party cosmetic brands into its portfolio, diversifying revenue streams beyond its legacy brand.
* **Asset Monetization & Debt Reduction:** To improve liquidity and reduce operational overhead, the Board has approved the **disposal of non-core manufacturing assets** (Land, Building, and Plant & Machinery) located at **Hosur (Shoolagiri)** to PKPL for an estimated value of approximately **₹3 Crore** (with a minimum floor price of **₹60,00,000**).
* **Property Divestment:** The company has also authorized the disposal of immovable property at **Pardi, Gujarat**, with an estimated realizable value of at least **₹60 Lakhs**. Proceeds are earmarked to address mortgages with **IDBI Bank** and enhance working capital.
---
### **Product Portfolio: Bridging Tradition and Modernity**
The company specializes in the **Traditional and Color Cosmetics** segment, reimagining ethnic staples through innovation in product formats to target both traditional users and the **Gen Z and millennial** demographics.
| Category | Key Products & Innovations |
| :--- | :--- |
| **Traditional Cosmetics** | **Bindis:** Evolved into designer fashion accessories with velvet textures and crystal embellishments. Recent launches include **antimicrobial bindis**. <br> **Kumkum & Sindoor:** Transitioned to liquid applicators in **Matte and Shimmer** formulations (e.g., Cheery Red and Scarlet Red). |
| **Eye Cosmetics** | **Kajal:** Positioned as a beauty-wellness hybrid (herbal, smudge-proof, and Ayurvedic). <br> **Eyeliner:** Rapidly expanding range including liquid, gel, pencil, and felt-tip pens. |
| **Color Cosmetics** | **Extended Range:** Includes foundational makeup such as lipstick, eyeshadow, mascara, blush, and nail polish. |
| **Niche Positioning** | **Clean Beauty:** Focus on organic, herbal, and cruelty-free formulations to meet the demand for products free from harsh chemicals. |
---
### **Market Dynamics & Growth Projections**
PCIL operates in a market where traditional accessories are being adopted as "style statements" for weddings and festivals.
* **Kajal Segment:** Projected CAGR of **8% - 10%**, driven by wellness benefits and the rise of male grooming.
* **Eyeliner Segment:** Market value projected to reach **USD 407.7 Million** by 2030 (CAGR of **2.7%**).
* **Traditional Segment:** Steady growth of **3% - 4%** supported by cultural resurgence.
**Strategic Growth Drivers:**
* **Digital Transformation:** Increasing presence on platforms like **Nykaa, Amazon, and Etsy**, while exploring **AI and Augmented Reality (AR)** for virtual try-ons.
* **Tier-II & Tier-III Expansion:** A 3-year plan to leverage the existing distribution network to reach deeper into rural and semi-urban India.
* **Export Strategy:** Positioning Bindis and Kumkum as global fashion accessories within the international **Ayurvedic beauty** trend.
---
### **Financial Profile & Capital Structure**
PCIL has maintained a stable but modest financial profile, with recent efforts focused on capital conservation and cost management.
**Three-Year Financial Summary (Audited):**
| Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Total Sales & Other Income** | **₹21.61 crore** | **₹23.89 crore** | **₹26.92 crore** |
| **Profit After Tax (PAT)** | **₹3.00 lakhs** | **₹2.14 lakhs** | **₹21.18 lakhs** |
| **Paid-up Equity Capital** | **₹4.86 crore** | **₹4.86 crore** | **₹4.86 crore** |
| **Dividend Declared** | **Nil** | **Nil** | **Nil** |
**Credit Ratings (as of March 2026):**
* **Long-Term Bank Facilities:** **CARE B; Stable** (Totaling **₹7.53 crore**).
* **Short-Term Bank Facilities:** **CARE A4** (Totaling **₹1.00 crore**).
* **Debt Profile:** Includes Term Loans and Cash Credit with interest rates ranging from **8.04% to 9.5%** (Bank) and **14% to 21%** (NBFC).
**Shareholding Pattern (as of March 31, 2025):**
* **Promoter Group:** **74.78%**
* **Public Holding:** **24.97%**
* **Dematerialization:** **90.84%** of total shares are held in electronic form.
---
### **Governance & Leadership Continuity**
To ensure stability during the business model transition, the company has secured long-term executive oversight:
* **MD Re-appointment:** **Mr. Hiitesh Topiiwaalla** has been re-appointed as Managing Director for a **5-year term** (April 2026 – March 2031).
* **Governance Amendment:** The **Articles of Association (AOA)** were altered in February 2026 to exempt the Managing Director from **retirement by rotation**, ensuring uninterrupted strategic leadership.
---
### **Risk Factors & Mitigation Strategies**
The company manages risks through a dedicated **Risk Management Committee**, focusing on the following critical areas:
**1. Statutory & Regulatory Liabilities:**
The company has significant outstanding undisputed statutory dues (as of March 31, 2025):
* **Income Tax & Interest:** **₹175.45 Lakhs**
* **Interest on TDS:** **₹15.12 Lakhs**
* **ESIC & PF Dues:** **₹13.10 Lakhs** (combined)
**2. Operational Risks:**
* **Inventory Management:** In **Q3 FY26**, the company wrote off **₹1.07 crore** in inventory due to spoilage and physical damage.
* **Counterfeiting:** The brand faces significant competition from the unorganized sector producing spurious products, which threatens both revenue and brand equity.
* **Currency Volatility:** Exposure to **USD-denominated import payables** is managed via **natural hedging**; the company does not currently use forward contracts.
**3. Market Risks:**
* **Consumer Trends:** Rapidly shifting preferences toward **eco-friendly packaging** and **natural formulations** require constant R&D.
* **Economic Sensitivity:** Inflation impacts discretionary spending; the company noted a weak festive boost in late 2023 with only **7% sales growth**.